← All companies
BridgeBio Pharma, Inc.
BBIO - CIK 0001743881
Market cap$13.20 B
Rank#791
SEC filings777
The table below shows BridgeBio Pharma, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $879.89M | $642.95M | $748.95M | $540.60M | $266.32M | $407.96M |
| Short-term investments | - | - | $7.94M | - | - | $39.81M |
| Receivables | $205.23M | $116.52M | $76.87M | $115.27M | - | - |
| Inventory | $32.98M | $24.53M | $18.28M | $3.95M | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.